CAC Software vs HealthCCSng

Direct competitors — feature-level head-to-head below. Comparability 95/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Imbio
VS
by Nano-X AI

AI Verdict

Both Imbio's CAC Software and Nano-X AI's HealthCCSng are highly comparable AI-powered solutions for automated coronary artery calcification (CAC) detection and quantification from non-contrast chest CT scans. While Imbio provides detailed outputs like arterial age and 3D visualizations, Nano-X AI emphasizes customizable CAC categorization and seamless integration with PACS/EMR systems for an automated workflow. Both tools serve the primary purpose of aiding in coronary artery disease risk assessment.

Choose CAC Software if…

Choose Imbio's CAC Software if your clinical workflow demands comprehensive quantitative analysis of coronary artery calcification, including metrics like arterial age, calcified lesion mass, and volume, alongside detailed 3D visualizations. This tool is particularly well-suited for in-depth risk assessment and scenarios where granular anatomical insights are critical for personalized patient management and research.

View CAC Software →

Choose HealthCCSng if…

Choose Nano-X AI's HealthCCSng if your primary need is an automated, high-throughput solution for routine coronary artery calcification screening from non-contrast CT scans across a large patient population. This tool is ideal for efficiently categorizing patients into predefined risk groups (e.g., zero, low, moderate, severe CAC) with minimal human intervention, streamlining integration into existing PACS and EMR systems for rapid risk stratification in a busy clinical environment.

View HealthCCSng →

When choosing between Imbio’s CAC Software and Nano-X AI’s HealthCCSng, physicians should consider their specific workflow and desired level of detail in coronary artery calcification (CAC) analysis. Both tools are FDA-cleared, HIPAA-compliant AI solutions designed to quantify CAC from non-contrast chest CT scans, aiding in coronary artery disease risk assessment. The core practical difference lies in the depth of their output and integration capabilities.

Imbio’s CAC Software excels in providing a comprehensive analysis, offering not only the Agatston score but also arterial age, calcified lesion mass, and volume, along with 3D visualizations and annotated images. This makes it ideal for cardiologists and radiologists who require detailed insights and visual aids for patient education and in-depth risk stratification. Its deployment flexibility across cloud, on-premise, and partner platforms may also appeal to institutions with specific IT infrastructure preferences.

Conversely, Nano-X AI’s HealthCCSng focuses on streamlined, automated detection and quantification, categorizing studies into ‘zero’, ‘low’, ‘moderate’, and ‘severe’ CAC categories with a numerical calcium score. Its strength lies in seamless integration with PACS and EMR systems, providing an automated workflow with results delivered without human intervention. This tool is particularly well-suited for practices prioritizing efficiency and automated risk categorization within their existing IT ecosystem, especially those who may not require the granular detail offered by Imbio’s solution.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CAC Software HealthCCSng
Pricing Contact for pricing Not publicly available
Deployment Cloud, On-premise, Partner platforms Cloud-based, integrates with PACS and EMR systems
FDA Status 1 AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools prioritize seamless integration into existing radiology workflows (DICOM, PACS, EMR) and automated processing without requiring significant user intervention. They both offer visualizations and aim to minimize disruption to clinical workflows, making it difficult to distinguish a clear winner in terms of overall usability without direct user feedback.

Clinical Value

HealthCCSng

HealthCCSng offers explicit categorization of CAC into 'zero', 'low', 'moderate', and 'severe' categories, along with customizable thresholds, which is highly valuable for clinical decision-making. A recent clinical study also highlighted its effectiveness in identifying previously undetected cardiovascular risk in a significant portion of patients.

Pricing & Value

HealthCCSng

While neither tool provides public pricing, HealthCCSng offers a clearer path to value for healthcare organizations by explicitly mentioning the availability of CPT codes for reimbursement and discussing its potential for revenue generation and attractive ROI. This transparency around financial benefits is a key differentiator.

Enterprise Readiness

CAC Software

Imbio's CAC Software offers greater deployment flexibility, explicitly supporting Cloud, On-premise, and Partner platforms, which caters to a wider range of enterprise IT infrastructures and preferences. Although both are FDA cleared and HIPAA compliant, Tool A's explicit BAA and diverse deployment options provide a stronger stance on enterprise readiness.

Innovation

CAC Software

Imbio's CAC Software demonstrates a slightly higher degree of innovation by providing more granular quantitative metrics beyond the standard Agatston score, such as arterial age, calcified lesion mass, and volume. Additionally, its capability to analyze various CT scan types, including low-dose and ungated scans, showcases advanced adaptability.

Support & Docs

CAC Software

Imbio provides clear and accessible information regarding its support channels, including phone and email contact details, specified support hours, and the availability of user manuals and other product documentation upon request. Tool B lacks specific public information on its support structure and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CAC Software HealthCCSng
Company Imbio Nano-X AI
Primary Purpose Automated image post-processing algorithms to determine location and calculate amount of calcification within coronary arteries from non-contrast chest CT. AI-powered solution that analyzes routine CT scans to automatically detect and quantify coronary artery calcification (CAC), identifying patients at risk of coronary artery disease.
Key Outputs/Scores Agatston score, arterial age, calcified lesion mass and volume; 3D visualizations and annotated images. Numerical calcium score; categorizes studies into 'zero', 'low', 'moderate', and 'severe' CAC categories; visualization of calcified plaques.
Input Scan Requirements Non-contrast, chest computed tomography (CT) Non-contrast, non-ECG gated chest CT scans
Integration Capabilities Integrates into existing DICOM viewing workflow Seamless integration with PACS and EMR systems

Videos

Demos, reviews, and walkthroughs featuring CAC Software and HealthCCSng.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio's CAC Software outputs the Agatston score, arterial age, calcified lesion mass, and volume. HealthCCSng generates a numerical calcium score and categorizes studies into 'zero', 'low', 'moderate', and 'severe' CAC categories.
Imbio's CAC Software integrates into existing DICOM viewing workflows. HealthCCSng offers seamless integration with PACS and EMR systems.
Imbio's CAC Software uses automated image post-processing algorithms. HealthCCSng provides an automated workflow for results without human intervention and allows for customizable CAC category configuration.
Imbio's CAC Software provides 3D visualizations and annotated images. HealthCCSng offers visualization of calcified plaques within coronary arteries.
Both tools analyze non-contrast chest CT scans. HealthCCSng specifically notes its ability to analyze non-contrast, non-ECG gated chest CT scans.
AI Tool Finder
AI-powered search. Results may not be comprehensive.